Mark leads the implementation of Venturewell’s strategy for growth, including the creation and execution of new partnerships and business opportunities. Mark currently serves as the VentureWell Principal Investigator and Project Director for the following programs/initiatives: The ARPANET-H Investor Catalyst Hub (ARPA-H); The Global Innovation through Science Technology initiative (US Department of State), the Rapid Acceleration of Diagnostics Initiative (National Institutes of Health), and the MedTech Challenge India: Market Acceleration and Training Award Program (Bill and Melinda Gates Foundation). Mark has 20+ years’ experience in U.S. and global health organizations leading operations, business development, board governance, program development, and administration. He has a background in molecular biology and infectious disease diagnostics and received a bachelors in Zoology and Neuroscience from Miami University (OH) and a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health.